« Previous
Next »
Journal of Vascular Surgery
Volume 48, Issue 3
, Pages 519-526
, September 2008
A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair
References
- . Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg. 1998;27:354–361
- . Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg. 1996;23:336–346
- . Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000;105:1641–1649
- Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg. 2000;31:325–342
- Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg. 2002;36:1–12
- . Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg. 1999;29:122–127discussion 127-9
- . Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscl Thromb Vasc Biol. 1999;19:1695–1699
- . Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. J Vasc Surg. 2002;35:916–922
- . Factors predictive of early or late aneurysm sac size change following endovascular repair. J Vasc Surg. 2006;43:649–656
- . Rate of change in abdominal aortic aneurysm diameter after endovascular repair. J Vasc Surg. 2000;32:108–115
- Variable sac behavior after endovascular repair of abdominal aortic aneurysm: analysis of core laboratory data. J Vasc Surg. 2004;39:95–101
- . Continued expansion of aortic necks after endovascular repair of abdominal aortic aneurysms (EVT Investigators. EndoVascular Technologies, Inc). J Vasc Surg. 1998;28:422–430discussion 430-1
- . Endograft migration one to four years after endovascular abdominal aortic aneurysm repair with the AneuRx device: a cautionary note. J Vasc Surg. 2002;36:476–484
- . Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts (A EUROSTAR report). J Vasc Surg. 2006;43:896–96
- Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318–326
- Plasma levels of metalloproteinases-3 and −9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation. 2001;104(12 Suppl 1):I288–I295
- . Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms. Adv Dent Res. 1998;12:159–165
- The “cyclic” regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol. 1996;67:506–514
- A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46:310–319
- . Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation. 1997;96:2228–2232
- Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair. Angiology. 2005;56:743–753
- . Mid- and long-term device migration after endovascular abdominal aortic aneurysm repair: a comparison of AneuRx and Zenith endografts. J Vasc Surg. 2005;42:392–401
- . The fate of the infrarenal aortic neck after open aneurysm surgery. J Vasc Surg. 1998;28:889–894
- . The role of aortic neck dilation and elongation in the etiology of stent graft migration after endovascular abdominal aortic aneurysm repair with a passive fixation device. J Vasc Surg. 2006;44:1176–1181
- Sac behavior after aneurysm treatment with the Gore Excluder low-permeability aortic endoprosthesis: 12-month comparison to the original Excluder device. J Vasc Surg. 2006;44:694–700
- Endovascular repair of abdominal aortic aneurysms: device-specific outcome. J Vasc Surg. 2003;37:991–998
Supported by grants from the Barnes-Jewish Hospital Foundation (J.A.C.), National Institutes for Health (5K08HL084004-02, J.A.C.), Department of Veteran's Affairs (J.A.C.), Flight Attendants Medical Research Institute (J.A.C.), and the American Heart Association (0765432Z, J.A.C.).
Competition of interest: Dr Geraghty has received consulting fees from W. L. Gore and Associates. Dr Sanchez has received consulting fees from W. L. Gore and Associates, Cook, and Medtronic.
PII: S0741-5214(08)00666-6
doi: 10.1016/j.jvs.2008.03.064
© 2008 The Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 48, Issue 3
, Pages 519-526
, September 2008
